Dorreen M S, Ironside J W, Bradshaw J D, Jakubowski J, Timperley W R, Hancock B W
Department of Medicine, Royal Hallamshire Hospital, Sheffield.
Q J Med. 1988 May;67(253):387-404.
Intracerebral disease was diagnosed in 14 out of 450 patients who presented with non-Hodgkin's lymphoma between January 1976 and January 1987. Twelve of the 14 presented after June 1980. Age ranged from 31 to 73 years and eight patients were male. Two patients had other tumours, and three had relevant associated immunosuppressive disorders. Radiological assessment of one further patient showed a cavitating bronchial carcinoma. Five patients were untreated, and one died before radiotherapy was complete. Eight patients completed courses of whole-brain irradiation; four of these received higher doses. All entered remission. Three patients are alive, between eight months and seven years after treatment. Of the remaining five, one never recovered intellectual function and died of bronchopneumonia; three died between eight and 30 months after treatment and autopsy showed severe radionecrosis of the brain with no residual tumour. All three had received higher doses of radiation and had undergone burrhole aspiration before treatment. Autopsy was refused on one patient who also appeared to have died from radionecrosis of the brain. Immunohistological examination in eight cases confirms that cerebral non-Hodgkin's lymphoma is a B-cell tumour. As other groups have found, its incidence appears to be rising. Survival rate is poor, and at least some deaths are related to both radiation necrosis and the bulk of residual tumour after diagnostic surgery.
在1976年1月至1987年1月期间出现非霍奇金淋巴瘤的450例患者中,有14例被诊断出患有脑内疾病。这14例中的12例在1980年6月之后出现。年龄范围为31岁至73岁,8例为男性。2例患有其他肿瘤,3例患有相关的免疫抑制性疾病。另有1例患者的放射学评估显示有空洞性支气管癌。5例患者未接受治疗,1例在放疗完成前死亡。8例患者完成了全脑照射疗程;其中4例接受了更高剂量的照射。所有患者均进入缓解期。3例患者在治疗后8个月至7年之间存活。其余5例中,1例从未恢复智力功能,死于支气管肺炎;3例在治疗后8至30个月之间死亡,尸检显示脑严重放射性坏死,无残留肿瘤。这3例患者均接受了更高剂量的放疗,并且在治疗前进行了钻孔抽吸。1例患者拒绝尸检,该患者似乎也死于脑放射性坏死。8例病例的免疫组织学检查证实,脑内非霍奇金淋巴瘤是一种B细胞肿瘤。正如其他研究组所发现的,其发病率似乎在上升。生存率很低,至少部分死亡与放射性坏死以及诊断性手术后残留肿瘤的大小有关。